🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/01/2004 | 54,54 | 55,21 | 52,63 | 53,86 | -0,55% | 4,74% | 144.217 |
| 28/01/2004 | 55,73 | 56,14 | 53,60 | 54,16 | -3,15% | 4,57% | 96.046 |
| 27/01/2004 | 55,81 | 56,14 | 54,65 | 55,92 | -0,40% | 2,68% | 137.217 |
| 26/01/2004 | 58,28 | 58,47 | 55,40 | 56,14 | -3,35% | 5,27% | 304.810 |
| 23/01/2004 | 57,75 | 58,50 | 57,27 | 58,09 | +0,32% | 2,14% | 232.569 |
| 22/01/2004 | 57,79 | 58,84 | 56,71 | 57,90 | -0,39% | 3,69% | 403.635 |
| 21/01/2004 | 56,11 | 58,43 | 55,25 | 58,13 | +4,16% | 5,67% | 272.831 |
| 20/01/2004 | 55,13 | 56,26 | 54,50 | 55,81 | +1,29% | 3,19% | 271.281 |
| 16/01/2004 | 55,13 | 55,62 | 53,64 | 55,10 | -0,07% | 3,60% | 164.975 |
| 15/01/2004 | 52,78 | 55,25 | 52,06 | 55,13 | +4,47% | 6,03% | 283.597 |
| 14/01/2004 | 52,74 | 52,81 | 51,43 | 52,78 | +1,15% | 2,63% | 187.337 |
| 13/01/2004 | 54,24 | 54,65 | 49,37 | 52,18 | -4,19% | 9,73% | 284.880 |
| 12/01/2004 | 53,82 | 55,25 | 52,51 | 54,46 | +1,04% | 5,08% | 721.377 |
| 09/01/2004 | 55,28 | 55,28 | 52,85 | 53,90 | -1,97% | 4,40% | 273.712 |
| 08/01/2004 | 54,24 | 56,22 | 52,40 | 54,98 | -3,99% | 7,04% | 1.099.605 |
| 07/01/2004 | 57,34 | 57,79 | 55,58 | 57,27 | +0,66% | 3,85% | 270.480 |
| 06/01/2004 | 55,81 | 57,57 | 55,58 | 56,89 | +2,08% | 3,55% | 277.640 |
| 05/01/2004 | 55,88 | 57,38 | 55,36 | 55,73 | -0,27% | 3,62% | 333.504 |
| 02/01/2004 | 55,36 | 56,48 | 55,21 | 55,88 | +1,63% | 2,30% | 239.274 |
| 31/12/2003 | 55,77 | 56,18 | 54,09 | 54,98 | -1,28% | 3,76% | 186.322 |
| 30/12/2003 | 55,73 | 56,14 | 55,21 | 55,70 | -0,33% | 1,68% | 91.932 |
| 29/12/2003 | 53,90 | 55,88 | 53,90 | 55,88 | +3,47% | 3,68% | 123.939 |
| 26/12/2003 | 54,80 | 55,13 | 53,56 | 54,01 | -1,50% | 2,87% | 41.731 |
| 24/12/2003 | 55,21 | 55,43 | 54,54 | 54,83 | -0,68% | 1,63% | 108.336 |
| 23/12/2003 | 55,02 | 55,47 | 52,89 | 55,21 | +0,75% | 4,69% | 186.375 |
| 22/12/2003 | 56,33 | 58,95 | 52,89 | 54,80 | -0,75% | 10,76% | 1.322.689 |
| 19/12/2003 | 53,34 | 55,40 | 53,19 | 55,21 | +1,65% | 4,14% | 261.957 |
| 18/12/2003 | 53,00 | 54,31 | 52,81 | 54,31 | +2,33% | 2,82% | 162.945 |
| 17/12/2003 | 54,20 | 54,83 | 52,63 | 53,08 | -2,07% | 4,07% | 124.820 |
| 16/12/2003 | 53,08 | 54,27 | 52,10 | 54,20 | +2,77% | 4,09% | 99.760 |